Provoked Craving Assessment

Completed · Phase 2 · Has a placebo group

Conditions studied: Smoking Dependence, Smoking

In brief

Evaluation of the ability of a nicotine mini lozenge to provide early relief of craving for a cigarette in smokers

Key facts

Study ID

NCT01506908

Run by

GlaxoSmithKline

People needed

323

Starts

2011-09-01

Expected to finish

2011-12-01

Last updated by the study team

2019-08-28

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Current cigarette smokers who have smoked regularly, and smoke more than 20 cigarettes per day on a regular basis for at least a year;
• Good general health with (in the opinion of the investigator) no clinically significant and relevant abnormalities of medical history.

You may not qualify if…

• Any disease that may interfere with the absorption, metabolism or excretion of the study product.
• A medical condition that might jeopardise the safety of the subject or the validity of the study results. For example, recent myocardial infarction or cerebrovascular incident (within 12 weeks of the screening visit), phenylketonuria, unstable or worsening angina pectoris, Prinzmetals angina or severe cardiac arrhythmia

Where it is running

• Los Angeles Clinical Trials — Burbank, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.